I agree with you Rev and have had those suspicions ever since FDA didn't go down the device route and requires additional trials. The CHMP did not express concerns about the performance of VitroGro® ECM, but is seeking additional data from the Company.
Tissue Therapies will attend an EMA Scientific Advisory Working Party (SAWP) meeting during May 2015 to agree on the studies that will satisfy the request for additional data.
Sorry to see this happen to holders who have stuck it out for the LT, all the best guys!
TIS Price at posting:
13.0¢ Sentiment: None Disclosure: Not Held
